Refsum's disease

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Cerebellar heredoataxia)
Jump to: navigation, search
Refsum's disease
Classification and external resources
Image:Phytanic acid.png
Phytanic acid
ICD-10 G60.1
ICD-9 356.3
OMIM 266500
DiseasesDB 11213
eMedicine derm/705 
MeSH D012035

WikiDoc Resources for

Refsum's disease

Articles

Most recent articles on Refsum's disease

Most cited articles on Refsum's disease

Review articles on Refsum's disease

Articles on Refsum's disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Refsum's disease

Images of Refsum's disease

Photos of Refsum's disease

Podcasts & MP3s on Refsum's disease

Videos on Refsum's disease

Evidence Based Medicine

Cochrane Collaboration on Refsum's disease

Bandolier on Refsum's disease

TRIP on Refsum's disease

Clinical Trials

Ongoing Trials on Refsum's disease at Clinical Trials.gov

Trial results on Refsum's disease

Clinical Trials on Refsum's disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Refsum's disease

NICE Guidance on Refsum's disease

NHS PRODIGY Guidance

FDA on Refsum's disease

CDC on Refsum's disease

Books

Books on Refsum's disease

News

Refsum's disease in the news

Be alerted to news on Refsum's disease

News trends on Refsum's disease

Commentary

Blogs on Refsum's disease

Definitions

Definitions of Refsum's disease

Patient Resources / Community

Patient resources on Refsum's disease

Discussion groups on Refsum's disease

Patient Handouts on Refsum's disease

Directions to Hospitals Treating Refsum's disease

Risk calculators and risk factors for Refsum's disease

Healthcare Provider Resources

Symptoms of Refsum's disease

Causes & Risk Factors for Refsum's disease

Diagnostic studies for Refsum's disease

Treatment of Refsum's disease

Continuing Medical Education (CME)

CME Programs on Refsum's disease

International

Refsum's disease en Espanol

Refsum's disease en Francais

Businness

Refsum's disease in the Marketplace

Patents on Refsum's disease

Experimental / Informatics

List of terms related to Refsum's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Refsum's disease (Refsum-Thiébaut disease, Refsum-Thiébaut-Klenk-Kahlke disease), named after Norwegian neurologist Sigvald Bernhard Refsum (1907-1991),[1][1] is neurological disease that results in the malformation of myelin sheaths around nerve cells. It is a peroxisomal disorder.

Causes

Refsum's disease is caused by faulty enzymes during the alpha-oxidation of phytanic acid resulting in buildup of phytanic acid and its unsaturated fatty acid derivatives in the plasma and tissues.

This in turn can be due to deficiencies of phytanoyl-CoA hydroxylase (chromosome 10) or peroxin-7 (chromosome 6).

Presentation

Patients with Refsum's Disease present with neurologic damage, cerebellar degeneration, and peripheral neuropathy. Onset is most commonly in childhood/adolescence with a progressive course, although periods of stagnation/remission occur.

Treatment

The most effective therapy in the classic Refsum disease is dietary treatment with a phytanic acid-restricted diet, such as exclusively avoiding consumption of beef, lamb, fatty fish such as tuna, cod, and haddock [1]. Recent research has shown that CYP4 isoform enzymes could eliminate the phytanic acid storage in vivo [1] and patients could try alternative natural remedies with either eatable marine invertebrates or with clofibrate supplement of which the component is usually rich in the excretion of high plant [1], [1], [1]. Currently, there is no clinical data to approve using this xenonbiotic drug for the treatment, perhaps due to its serious adverse effect [1]and the major medical treatment of the disease only relies on the plasmapheresis.

Reaction

Phytol (from chlorophyll in plant foods) ---> phytanic acid -x-> pristanic acid ---> propionyl CoA

See also

References

de:Refsum-Syndrom

fr:Maladie de Refsum no:Refsums sykdomfi:Refsumin tauti


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages